CSI Market
Sign In | Register

Ortho Clinical Diagnostics Holdings Plc (OCDX) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access OCDX Annual Income Statement →
The data below summarizes Ortho Clinical Diagnostics Holdings Plc's income statement results from Apr 04 2021 to Apr 03 2022, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Apr 03 2022)
Q1 2022 		(Jan 02 2022) (Oct 03 2021) (Jul 04 2021) (Apr 04 2021)
Revenues
Sales of Products495.20
Total Revenue500.10
Costs & Expenses
Cost of Goods and Services Sold249.50
Gross Profit250.60
Selling, Administration, Marketing129.50
Depreciation & Amortization33.20
Research and Development Expense32.20
Restructuring, Accretion & Impairment Charges5.70
Other Operating Expense / -Income8.60
Total operating costs including COS453.00
Operating income / -loss47.10
Interest Expense32.50
Net Interest Expense / -Income32.50
Extinguishment of Debt0.00
Foreign Currency Transaction (Gain) Loss1.70
Other loss / -income-3.50
Total costs & expenses481.80
Income & Taxes
Income / -loss before income taxes18.30
Income taxes expenses / -benefit3.50
Income after income taxes14.80
Net income / -loss of other equity0.00
Income / -loss from continuing operations14.80
Net income / -loss14.80
Income / -loss to shareholder14.80
EBIT50.80
EBITD130.20
EBITDA132.20
Earnings Per Share
Basic EPS (excl. extra items)0.06
Basic Net EPS0.06
Basic shares outstanding (Mill. of Units)237.20
Diluted Net EPS0.06
Diluted average shares (Mill. of Units)242.00
4 historic quarters locked

Sign in to unlock the full Ortho Clinical Diagnostics Holdings Plc income statement history.

Sign In Create Free Account

About OCDX Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.